These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38177854)

  • 1. A society-wide conversation is needed about germline genome editing using CRISPR.
    Birney E
    Nat Med; 2024 Jan; 30(1):30-32. PubMed ID: 38177854
    [No Abstract]   [Full Text] [Related]  

  • 2. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
    Maier LK; Marchfelder A; Randau L
    Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
    [No Abstract]   [Full Text] [Related]  

  • 3. CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants.
    Liu H; Ding Y; Zhou Y; Jin W; Xie K; Chen LL
    Mol Plant; 2017 Mar; 10(3):530-532. PubMed ID: 28089950
    [No Abstract]   [Full Text] [Related]  

  • 4. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
    Meyer M
    EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient multiplex genome editing by CRISPR/Cas9 in common wheat.
    Li J; Zhang S; Zhang R; Gao J; Qi Y; Song G; Li W; Li Y; Li G
    Plant Biotechnol J; 2021 Mar; 19(3):427-429. PubMed ID: 33150679
    [No Abstract]   [Full Text] [Related]  

  • 8. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
    Verhage L
    Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
    [No Abstract]   [Full Text] [Related]  

  • 9. Celebrating a Decade of CRISPR-Fueled Genome Editing.
    Barrangou R
    CRISPR J; 2022 Jun; 5(3):354-355. PubMed ID: 35686974
    [No Abstract]   [Full Text] [Related]  

  • 10. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 12. Upstream Ethical Mapping of Germline Genome Editing.
    Halpern J; Paolo D
    Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
    [No Abstract]   [Full Text] [Related]  

  • 13. Refining CRISPR-based genome and epigenome editing off-targets.
    Luo Y
    Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
    [No Abstract]   [Full Text] [Related]  

  • 14. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
    Wang W; Hou J; Zheng N; Wang X; Zhang J
    Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene editing and gene regulation with CRISPR.
    Harrison P; Hart S
    Exp Physiol; 2018 Apr; 103(4):437-438. PubMed ID: 29603460
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
    Locke LG
    CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 19. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypercompact CRISPR-Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants.
    Liu S; Sretenovic S; Fan T; Cheng Y; Li G; Qi A; Tang X; Xu Y; Guo W; Zhong Z; He Y; Liang Y; Han Q; Zheng X; Gu X; Qi Y; Zhang Y
    Plant Commun; 2022 Nov; 3(6):100453. PubMed ID: 36127876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.